Details der Publikation - Exploring liver fibrosis biomarkers in non-alcoholic fatty liver disease (NAFLD)

Medienart:	Klinische Studie

Erscheinungsjahr:	2023
Erschienen:	2023

Enthalten in:	WHO International Clinical Trials Registry Platform - (2023) vom: 08. Mai Zur Gesamtaufnahme - year:2023

Sprache:	Unbestimmt

Links:	Volltext [kostenfrei]

Themen:	610 Medical Condition: NAFLD/NASH Recruitment Status: Complete: follow-up complete Study Type: Observational

Anmerkungen:	WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 23-04-2019, Last updated: 2023-05-23

ICTRP ID:	JPRN-UMIN000036576

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	CTG004798236


LEADER	01000caa a22002652 4500
001	CTG004798236
003	DE-627
005	20230523091339.0
007	cr uuu---uuuuu
008	210507s2023 xx \|\|\|\|\|o 00\| \|\|und c
035			\|a (DE-627)CTG004798236
035			\|a (UBBS_Klinische_Studien_WHO)JPRN-UMIN000036576
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a und
245	1	0	\|a Exploring liver fibrosis biomarkers in non-alcoholic fatty liver disease (NAFLD) \|b Exploring liver fibrosis biomarkers in non-alcoholic fatty liver disease (NAFLD) - Exploring liver fibrosis biomarkers in non-alcoholic fatty liver disease (NAFLD)
264		1	\|c 2023
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 23-04-2019, Last updated: 2023-05-23
650		4	\|a Medical Condition: NAFLD/NASH
650		4	\|a Study Type: Observational
650		4	\|a Recruitment Status: Complete: follow-up complete
650		4	\|a 610
773	0	8	\|i Enthalten in \|t WHO International Clinical Trials Registry Platform \|g (2023) vom: 08. Mai
773	1	8	\|g year:2023 \|g day:08 \|g month:05
856	4	0	\|u https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041673 \|z kostenfrei \|3 Volltext
912			\|a GBV_CTG
951			\|a AR
952			\|j 2023 \|b 08 \|c 05